Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Effect of combined renal denervation and pulmonary vein isolation in atrial fibrillation recurrence in hypertensive patients: A meta-analysis
PACE - Pacing and Clinical Electrophysiology, Volume 43, No. 8, Year 2020
Notification
URL copied to clipboard!
Description
Background: Atrial Fibrillation (AF) is the most common cardiac arrhythmia and hypertension is the most common risk factor associated with AF. The addition of renal sympathetic nerve denervation (RSDN) to pulmonary vein isolation (PVI) in AF patients with hypertension has been reported to improve clinical outcomes. Methods: A systematic search was performed for studies on patients with AF and hypertension that compared RSDN with PVI versus PVI-alone. Risk ratio (RR) for categorical variables and mean difference (MD) for continuous variables with 95% confidence intervals were used. Results: Seven studies with a total of 734 patients were included. A total of 340 patients were in the RSDN + PVI group (46.32%) and 394 (53.67%) in the PVI group. A total of 608 patients had paroxysmal AF (83%) while 126 patients had persistent AF (17%). At 12 months follow-up, RSDN + PVI decreased the overall risk of AF recurrence in hypertensive patients with RR 0.60 [95% CI 0.50-0.72, P <.00001]. A subgroup analysis performed in patients with drug-resistant hypertension showed a similar reduction in AF recurrence with RR 0.61 [95% CI: 0.47-0.79, P =.0002). Procedure duration MD + 28.05 min [95% CI: 18.88-37.23, P <.00001] and fluoroscopy duration MD + 5.59 min [95% CI: 3.31-8.19, P <.00001] were significantly longer with the RSDN + PVI group. There was no significant difference in complications between the two groups. Conclusion: The addition of RSDN to PVI in patients with AF and hypertension appears safe and decreases AF recurrence. Similar results were observed in patients with drug-resistant hypertension. Larger trials are needed to confirm these results. © 2020 Wiley Periodicals LLC
Authors & Co-Authors
Mujer, Mark Terence P.
United States, East Lansing
Michigan State University
Al-Abcha, Abdullah
United States, East Lansing
Michigan State University
Saleh, Yehia
United States, East Lansing
Michigan State University
Boumegouas, Manel
United States, East Lansing
Michigan State University
Herzallah, Khader
United States, East Lansing
Michigan State University
Statistics
Citations: 5
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1111/pace.14009
ISSN:
01478389
Research Areas
Noncommunicable Diseases
Study Design
Cohort Study
Study Approach
Systematic review